Key Takeaway: Compass Pathways plc will attend the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026. The company aims to discuss new treatment options in mental health care. Management will participate in a fireside chat scheduled for 1:00pm ET, which will be available via a live audio webcast.
Market Sentiment Analysis
POSITIVE FACTORS
Compass Pathways is actively engaging in important discussions on mental health.
Participation in the summit highlights the company's commitment to innovation.
The event provides a platform for sharing insights on neuropsychiatry.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+247%
120-day peak, hindsight
Typical move
8.5%
average across 2 past catalysts
Cash runway
~31 mo
Minimal dilution risk
Lead asset
COMP360 psilocybin
Phase 2 · PTSD - Post Traumatic Stress Disorder
Full Press Release Details
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026 and will participate in a fireside chat at 1:00pm ET. A live audio webcast of the fireside chat will be accessible at the following link: https://event.summitcast.com/view/fAK4ioHxQNLX5
Frequently Asked Questions
When will Compass Pathways participate in the summit?
Compass Pathways will participate in the summit on September 23, 2026.
What time is the fireside chat scheduled?
The fireside chat is scheduled for 1:00pm ET.
How can I access the fireside chat?
The fireside chat will be accessible via a live audio webcast.
What is the focus of the TD Cowen summit?
The summit focuses on novel mechanisms in neuropsychiatry.